- Report
- September 2025
- 250 Pages
Global
From €4081EUR$4,490USD£3,509GBP
- Report
- April 2025
- 200 Pages
Global
From €4081EUR$4,490USD£3,509GBP
- Report
- March 2025
- 175 Pages
Global
From €4081EUR$4,490USD£3,509GBP
- Report
- September 2024
- 323 Pages
Global
From €4545EUR$5,000USD£3,908GBP
- Report
- July 2024
- 339 Pages
Global
From €4545EUR$5,000USD£3,908GBP
- Report
- June 2023
- 340 Pages
Global
From €4545EUR$5,000USD£3,908GBP
- Report
- August 2025
- 187 Pages
Global
From €3222EUR$3,545USD£2,771GBP
€3580EUR$3,939USD£3,079GBP
- Report
- August 2025
- 199 Pages
Global
From €3222EUR$3,545USD£2,771GBP
€3580EUR$3,939USD£3,079GBP
- Report
- February 2024
- 187 Pages
Global
From €4090EUR$4,500USD£3,517GBP
- Report
- February 2021
Global
From €4045EUR$4,450USD£3,478GBP
- Report
- January 2023
- 295 Pages
Global
From €3636EUR$4,000USD£3,126GBP
- Report
- July 2024
- 150 Pages
Global
From €3409EUR$3,750USD£2,931GBP
- Report
- July 2024
- 100 Pages
Global
From €3409EUR$3,750USD£2,931GBP
- Report
- July 2025
- 236 Pages
Global
From €2272EUR$2,500USD£1,954GBP
- Report
- December 2024
- 207 Pages
Global
From €2272EUR$2,500USD£1,954GBP
- Report
- April 2024
- 181 Pages
Global
From €4090EUR$4,500USD£3,517GBP
- Report
- February 2024
- 115 Pages
Global
From €4318EUR$4,750USD£3,712GBP
- Report
- November 2024
- 66 Pages
Global
From €1773EUR$1,950USD£1,524GBP
- Report
- June 2022
- 73 Pages
Global
From €1773EUR$1,950USD£1,524GBP
- Report
- August 2023
- 215 Pages
Global
€4359EUR$4,795USD£3,748GBP

The Drug Discovery AI market is a rapidly growing sector of the pharmaceutical industry, focused on the development of artificial intelligence (AI) technologies to aid in the discovery of new drugs. AI-driven drug discovery is a process that uses machine learning algorithms to identify potential drug targets and develop new drug candidates. AI-driven drug discovery can reduce the time and cost of drug development, as well as improve the accuracy of drug discovery.
The Drug Discovery AI market is composed of a variety of companies, ranging from large pharmaceutical companies to small startups. Companies in the market include Atomwise, Exscientia, Insilico Medicine, and Recursion Pharmaceuticals. These companies are developing AI-driven drug discovery technologies to help accelerate the drug discovery process. Show Less Read more